Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M101,298Revenue $M16,560Net Margin (%)9.8Altman Z-Score6.0
Enterprise Value $M103,353EPS $1.0Operating Margin %11.4Piotroski F-Score7
P/E(ttm)57.5Beneish M-Score-2.1Pre-tax Margin (%)13.1Higher ROA y-yN
Price/Book6.710-y EBITDA Growth Rate %-1.4Quick Ratio1.7Cash flow > EarningsY
Price/Sales8.35-y EBITDA Growth Rate %-14.3Current Ratio1.8Lower Leverage y-yY
Price/Free Cash Flow96.4y-y EBITDA Growth Rate %-0.6ROA % (ttm)5.9Higher Current Ratio y-yY
Dividend Yield %2.5PEG--ROE % (ttm)12.9Less Shares Outstanding y-yN
Payout Ratio %140Shares Outstanding M1,668ROIC % (ttm)8.0Gross Margin Increase y-yY

Gurus Latest Trades with BMY

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
BMYT Rowe Price Equity Income Fund 2015-12-31 Reduce-0.26%$59.88 - $70.71
($66.18)
$ 60.72-8%Reduce -18.01%4,520,000
BMYVanguard Health Care Fund 2015-12-31 Add0.12%$59.88 - $70.71
($66.25)
$ 60.72-8%Add 1.95%46,232,449
BMYKahn Brothers 2015-12-31 Reduce-0.01%$59.88 - $70.71
($66.25)
$ 60.72-8%Reduce -2.60%28,050
BMYKen Fisher 2015-12-31 Add0.01%$59.88 - $70.71
($66.18)
$ 60.72-8%Add 120.33%134,800
BMYMario Gabelli 2015-12-31 Reduce$59.88 - $70.71
($66.25)
$ 60.72-8%Reduce -1.85%639,355
BMYVanguard Health Care Fund 2015-09-30 Add0.21%$57.3 - $70.06
($63.44)
$ 60.72-4%Add 3.72%45,346,149
BMYT Rowe Price Equity Income Fund 2015-09-30 Reduce-0.08%$57.3 - $70.06
($63.44)
$ 60.72-4%Reduce -5.20%5,512,700
BMYMario Gabelli 2015-09-30 Reduce-0.01%$57.3 - $70.06
($63.44)
$ 60.72-4%Reduce -4.01%651,417
BMYGeorge Soros 2015-09-30 Buy 0.01%$57.3 - $70.06
($63.44)
$ 60.72-4%New holding5,000
BMYJoel Greenblatt 2015-09-30 Buy 0.01%$57.3 - $70.06
($63.44)
$ 60.72-4%New holding21,863
BMYRonald Muhlenkamp 2015-09-30 Add$57.3 - $70.06
($63.44)
$ 60.72-4%Add 0.06%211,750
BMYDodge & Cox 2015-09-30 Reduce$57.3 - $70.06
($63.44)
$ 60.72-4%Reduce -1.24%79,928
BMYKen Fisher 2015-09-30 Add$57.3 - $70.06
($63.44)
$ 60.72-4%Add 76.64%61,180
BMYVanguard Health Care Fund 2015-06-30 Add0.11%$63 - $69.15
($65.88)
$ 60.72-8%Add 1.90%43,718,751
BMYRonald Muhlenkamp 2015-06-30 Reduce-0.01%$63 - $69.15
($65.88)
$ 60.72-8%Reduce -0.26%211,620
BMYMario Gabelli 2015-06-30 Reduce-0.01%$63 - $69.15
($65.88)
$ 60.72-8%Reduce -3.66%678,636
BMYFirst Eagle Investment 2015-06-30 Reduce$63 - $69.15
($65.88)
$ 60.72-8%Reduce -8.05%13,325
BMYDodge & Cox 2015-06-30 Reduce$63 - $69.15
($65.88)
$ 60.72-8%Reduce -7.86%80,928
BMYKahn Brothers 2015-06-30 Add$63 - $69.15
($65.88)
$ 60.72-8%Add 1.41%28,800
BMYKen Fisher 2015-06-30 Add$63 - $69.15
($65.88)
$ 60.72-8%Add 6.77%34,636
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

BMY is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


BMY: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
ANDREOTTI LAMBERTODirector 2016-01-05Sell23,200$67.56-10.98view
ANDREOTTI LAMBERTODirector 2015-12-15Sell23,200$69.03-12.88view
ANDREOTTI LAMBERTODirector 2015-11-20Sell23,200$67.39-10.76view
ANDREOTTI LAMBERTODirector 2015-10-06Sell23,200$60.86-1.18view
ANDREOTTI LAMBERTODirector 2015-09-03Sell23,200$59.41.25view
ANDREOTTI LAMBERTODirector 2015-08-03Sell315,000$65.36-7.99view
Caldarella Joseph CSVP & Controller 2015-06-04Sell16,972$65.71-8.48view
Schmukler Louis SPres., Global Mfg. & Supply 2015-03-16Sell12,000$66.96-10.19view
Cuss Francis MEVP & CSO 2015-03-16Sell114,666$67.81-11.31view
Moed Samuel JSVP, Strat Plan & Analysis 2015-03-13Sell591$66.67-9.79view

Press Releases about BMY :

Quarterly/Annual Reports about BMY:

    News about BMY:

    Articles On GuruFocus.com
    10 Fund Managers Are Totally Wrong on GlaxoSmithKline Jan 26 2016 
    5 Top Stocks of the Outperforming Vanguard Health Care Fund Dec 28 2015 
    Designing the Appropriate Common Stock Retirement Portfolio: Stock Selection Options Part 1 Sep 14 2015 
    Weekly Insider Sells Highlight: IMS, NOW, BMY, EA Aug 11 2015 
    Will Bill Ackman Go After Express Scripts Next? Jun 30 2015 
    Bristol-Myers Squibb Takes A Step Up On Cancer Drugs, But The Cost Tells A Different Story Jun 22 2015 
    Abbvie Inc. Dividend Stock Analysis May 26 2015 
    Baxter Takes The Acquisition Route To Grow In The Oncology Segment May 14 2015 
    Bayer Enters Into Collaboration With Isis For Enhancing Its Drug Portfolio May 07 2015 
    Vanguard Adds to Four of Its Largest Stakes May 04 2015 

    More From Other Websites
    Where is Ronald Reagan When You Need Him? Feb 08 2016
    12:48 pm Bristol-Myers: FDA approves expanded use of Daklinza in combination with sofosbuvir in... Feb 07 2016
    U.S. FDA Approves Expanded Use of Bristol-Myers Squibb’s Daklinza (daclatasvir) for Additional... Feb 05 2016
    Growth, Factors at Play - Analyst Notes on General Electric, Dow Chemical, Bristol-Myers Squibb and... Feb 04 2016
    Bristol-Myers Squibb to Take Part in Leerink Swann Global Healthcare Conference Feb 03 2016
    Merck gives cautious 2016 outlook as sales of top medicines lag Feb 03 2016
    Pfizer earnings fall but tops Street 4Q forecasts Feb 02 2016
    Pfizer earnings fall but tops Street 4Q forecasts Feb 02 2016
    Bristol-Myers Squibb Co. Earnings Analysis: Q4, 2015 By the Numbers Feb 02 2016
    Bristol-Myers Squibb Foundation Awards Eight Grants Totaling Nearly $11.5M to Make Lung and Skin... Feb 01 2016
    Bristol-Myers Squibb Foundation Awards Eight Grants Totaling Nearly $11.5M to Make Lung and Skin... Feb 01 2016
    Technical Pointers on Drug Manufacturers - Major Stocks -- Bristol-Myers Squibb, Eli Lilly,... Feb 01 2016
    Bristol-Myers Squibb and Pfizer Sign Collaboration with Portola Pharmaceuticals to Develop and... Feb 01 2016
    Bristol-Myers Squibb and Pfizer Sign Collaboration with Portola Pharmaceuticals to Develop and... Feb 01 2016
    Bristol-Myers Squibb and Pfizer Sign Collaboration with Portola Pharmaceuticals to Develop and... Feb 01 2016
    Adversity Creates Opportunity Feb 01 2016
    Bristol-Myers' Daklinza-Sovaldi Label Expanded in the EU Jan 29 2016
    What Will Cure Bristol-Myers Squibb? Jan 29 2016
    Bristol-Myers Squibb and AbbVie Receive Positive CHMP Opinion for Investigational Antibody,... Jan 29 2016
    Edited Transcript of BMY earnings conference call or presentation 28-Jan-16 3:30pm GMT Jan 29 2016

    Add Notes, Comments

    If you want to ask a question or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    FEEDBACK